Tag: mock audits

Case Studies: Remote/Virtual Inspection Readiness That Turned High-Risk Programs Inspection-Ready In the ever-evolving landscape of clinical research, the shift towards remote and virtual inspection methodologies has gained momentum, especially in light of recent global challenges. As regulatory authorities in the US, UK, and EU embrace these methodologies, the importance of preparing for inspections, even in…

Read More “Case Studies: Remote/Virtual Inspection Readiness That Turned High-Risk Programs Inspection-Ready” »

Integrating Remote/Virtual Inspection Readiness With CAPA, Training and Change Control Integrating Remote/Virtual Inspection Readiness With CAPA, Training and Change Control Introduction to Remote and Virtual Inspection Readiness in Clinical Trials The recent paradigm shifts in clinical trials have necessitated a reevaluation of inspection readiness, particularly in the context of remote and virtual audits. As organizations…

Read More “Integrating Remote/Virtual Inspection Readiness With CAPA, Training and Change Control” »

Remote/Virtual Inspection Readiness: End-to-End Blueprint for Health Authority Inspections In the landscape of clinical research, ensuring readiness for health authority inspections is paramount. With the increase in remote and virtual inspections as a response to global circumstances, it is essential for clinical operations, regulatory affairs, and medical affairs professionals to understand how to efficiently prepare….

Read More “Remote/Virtual Inspection Readiness: End-to-End Blueprint for Health Authority Inspections” »

How to Design Remote/Virtual Inspection Readiness That Stands Up to FDA, EMA and MHRA Scrutiny How to Design Remote/Virtual Inspection Readiness That Stands Up to FDA, EMA and MHRA Scrutiny As the landscape of clinical trials evolves, particularly with the increasing prevalence of remote and virtual inspections, the importance of being prepared for scrutiny from…

Read More “How to Design Remote/Virtual Inspection Readiness That Stands Up to FDA, EMA and MHRA Scrutiny” »

Remote/Virtual Inspection Readiness in Practice: Step-by-Step Guide for Clinical Quality Leaders In an era where remote and decentralized clinical trials are becoming the norm, ensuring inspection readiness in virtual settings poses unique challenges and opportunities. This guide provides a comprehensive step-by-step approach for clinical quality leaders to enhance their readiness for remote inspections, focusing on…

Read More “Remote/Virtual Inspection Readiness in Practice: Step-by-Step Guide for Clinical Quality Leaders” »

Common GCP Findings Linked to Weak Remote/Virtual Inspection Readiness—and How to Prevent Them Common GCP Findings Linked to Weak Remote/Virtual Inspection Readiness—and How to Prevent Them Introduction The landscape of clinical trials has evolved significantly, especially with the rise of decentralized and remote clinical trial models. This transformation allows for greater patient accessibility and flexibility…

Read More “Common GCP Findings Linked to Weak Remote/Virtual Inspection Readiness—and How to Prevent Them” »

Aligning Remote/Virtual Inspection Readiness With TMF, QMS and Risk-Based Quality Management Aligning Remote/Virtual Inspection Readiness With TMF, QMS and Risk-Based Quality Management In the dynamic landscape of clinical research, preparation for remote or virtual inspections has become paramount, especially in the wake of the COVID-19 pandemic. Efficient alignment of Trial Master File (TMF), Quality Management…

Read More “Aligning Remote/Virtual Inspection Readiness With TMF, QMS and Risk-Based Quality Management” »